How much probiotic do you need per day?
There is no universal daily dose for probiotics: how much you need depends strongly on the bacterial strain, the application, and your specific complaint. Always choose a product that has been studied specifically for your situation, and when in doubt consult your doctor or pharmacist.
The dose at which probiotics show an effect varies considerably depending on the application. In children receiving antibiotics, a dose of 10 billion CFU (colony-forming units) per day had no significant effect on strictly defined antibiotic-associated diarrhoea. That same dose did reduce the overall risk of diarrhoea during and shortly after the course of antibiotics, by roughly 35% relative risk reduction. A fixed 'good dose' therefore does not exist: it depends on what you want to achieve and which strains you are taking.
For recurring gut-bacterial infections (Clostridioides difficile, a dangerous hospital-acquired bacterium), dose clearly mattered. A dose of 8 billion CFU per day reduced relapse from 45.5% to 13.8%. A lower dose of 1.6 billion CFU showed no demonstrable effect. This concerns a specific, experimental probiotic mixture of eight bacterial strains; larger studies still need to confirm this.
In young children with an upper respiratory tract infection, a mixture of three specific bacterial strains taken for two weeks shortened the duration of fever by an average of two days. The available data do not give a fully conclusive answer on the exact CFU dose in this case. In adults with severe depression, 10 billion CFU of one specific Bifidobacterium strain showed a statistically significant effect on mood scores after four weeks, but the study included only 45 participants and is therefore purely exploratory.
Important to know: the WHO explicitly advises against probiotics in children with acute watery diarrhoea, because the evidence for this is too weak and too uncertain. Probiotics are therefore certainly not always the appropriate choice, even for 'obvious' complaints such as diarrhoea in children.
All claims are based on multiple controlled studies (one RCT in children receiving antibiotics PMID 35727573, one RCT in respiratory tract infections PMID 40085083, one small RCT in depression PMID 34875345, one phase-2 RCT in C. difficile PMID 37060545, and WHO guideline 2024 PMID 40839064). None of these studies provides a universal dosing recommendation; each application has its own strains and doses.